Is drug repurposing safe?

Repurposed drugs have a known safety profile from their original approval, which is the main advantage. But every drug carries side-effect risks, and a repurposed drug used off-label for a new indication still requires clinical evaluation and a clinician's judgment. RepurposeX surfaces hypotheses, not treatment recommendations.

Can drug repurposing help with rare diseases?

Yes. Drug repurposing is especially valuable for rare diseases where developing a new drug from scratch isn't economically feasible. Repurposing existing approved drugs can shortcut years of development and is often the only viable path to a treatment for orphan conditions.

Yes. RepurposeX is free, open, and has no ads. It's built on top of public biomedical databases and exists to make drug-repurposing research accessible to anyone (researchers, patients, clinicians, or curious students).

What's the difference between drug repurposing and off-label use?

Off-label use is when a clinician prescribes an approved drug for a condition it isn't FDA-labeled for, based on their judgment of the evidence. Drug repurposing is the systematic search for new indications, often followed by formal clinical trials and regulatory submissions to add the new indication to the drug's label. Off-label use is a clinical decision; drug repurposing is a research and development pathway.

Guide

What is drug repurposing?

Q: What is drug repurposing?

Drug repurposing (also called drug repositioning) is the process of finding new uses for existing FDA-approved drugs. Because the drug is already proven safe in humans, the path to a new indication is faster, cheaper, and lower-risk than developing a brand-new compound. Famous examples include Viagra (originally for chest pain), Botox (originally for crossed eyes), Minoxidil (originally for high blood pressure), and Aspirin (originally for pain, now standard for heart-attack prevention).

Q: How does RepurposeX find drug repurposing candidates?

RepurposeX queries the world's largest open biomedical databases (Open Targets, ChEMBL, ClinicalTrials.gov, openFDA, DGIdb, and PubMed) and surfaces approved drugs that act on genes linked to a disease they aren't yet approved to treat. Each candidate is scored on gene-disease association strength, literature density, novelty, and per-drug safety flags.

Drug repurposing (also called drug repositioning) is the process of finding new medical uses for existing FDA-approved drugs. Because a repurposed drug already has a known safety profile from its original approval, getting it to patients with a new condition is faster, cheaper, and lower-risk than developing a brand-new compound from scratch.

Famous drug repurposing examples

Many household-name drugs were originally developed for something completely different.

Viagra (sildenafil)
Made forAngina (chest pain)Now used forErectile dysfunction
Pfizer pivoted after male volunteers in Phase I trials reported a side effect they wanted to keep.
Botox
Made forCrossed eyes and eyelid spasmsNow used forCosmetic, chronic migraine, overactive bladder
First approved in 1989 for strabismus. Doctors noticed it also smoothed forehead wrinkles. Today it has a half-dozen FDA indications.
Minoxidil (Rogaine)
Made forSevere high blood pressureNow used forHair loss
Patients on the oral blood-pressure pill grew hair everywhere. Researchers reformulated it as a topical foam.
Bupropion (Zyban)
Made forDepressionNow used forQuitting smoking
Patients on this antidepressant noticed cigarettes felt less satisfying. The same molecule was repackaged as Zyban.
Aspirin
Made forPain and feverNow used forPreventing a second heart attack or stroke
A 1900s headache pill. In low daily doses, it thins the blood enough to lower clot risk for adults who've already had a cardiac event.
Thalidomide
Made forMorning sickness (later withdrawn)Now used forLeprosy and multiple myeloma
One of the worst drug disasters in history was repurposed decades later for indications where its anti-inflammatory effects mattered.

Why drug repurposing matters

Developing a new drug from scratch typically costs over $1 billion and takes 10 to 15 years, with a 90%+ failure rate at every stage. Drug repurposing shortcuts this in three ways:

01
Safety is already known. The drug has cleared toxicity, dosing, and long-term safety trials for its original indication.
02
Manufacturing exists. The supply chain, regulatory expertise, and clinical infrastructure are already in place.
03
Time-to-trial is months, not years. A candidate can enter a new indication trial almost immediately. For rare diseases where the patient population is too small to justify building a drug from scratch, repurposing is often the only viable path to a treatment.

How RepurposeX surfaces candidates

RepurposeX queries six open biomedical databases (Open Targets, ChEMBL, ClinicalTrials.gov, openFDA, DGIdb, and PubMed) to find approved drugs that act on genes linked to a disease they aren't yet approved to treat. Each candidate is scored on four signals:

AssociationHow strongly the gene is linked to the disease, with circular drug-evidence removed for a cleaner signal.
LiteratureHow well-studied the (drug, disease) pair is in PubMed.
NoveltyWhether anyone has tried this drug for this disease before.
SafetyDown-ranks drugs with FDA boxed warnings or market withdrawals.

The result is a short list of candidates worth investigating, never a treatment recommendation. See the full data methodology.

Drug repurposing vs. off-label use

People often confuse the two. They're related but distinct.

Off-label use

A clinician prescribes an FDA-approved drug for a condition it isn't labeled for, based on their judgment of the evidence. A patient-by-patient clinical decision.

Drug repurposing

The systematic, research-driven search for new indications, usually followed by formal clinical trials and a regulatory submission to add the new indication to the drug's label. A development pathway.

The two often inform each other. A widely-used off-label practice can become the basis for a formal repurposing trial.

Who is this for?

RepurposeX is free, open, no ads, no tracking, no paywall. It was built for:

ResearchersAcademic and industry teams hunting for repurposing leads.
CliniciansWeighing off-label options for hard-to-treat patients.
Patient advocatesFamily members of someone with a rare disease, looking for any credible avenue.
Curious learnersAnyone who wants to see how the world's biomedical knowledge graph is wired together.

Try it

Search a disease or drug →

Methodology

Where the data comes from →

Important: RepurposeX surfaces drug-repurposing hypotheses based on biological evidence, not medical advice. Nothing on this site is a treatment recommendation. Always consult a qualified clinician before starting, stopping, or changing any medication.